Ramsay N K, Kim T H, McGlave P, Goldman A, Nesbit M E, Krivit W, Woods W G, Kersey J H
Blood. 1983 Sep;62(3):622-6.
A preparative regimen, consisting of total lymphoid irradiation and cyclophosphamide, was utilized in 40 patients with severe aplastic anemia undergoing allogeneic marrow transplantation. This regimen was successful in decreasing rejection in these previously transfused patients, as only one patient rejected the marrow graft. Twenty-nine of the 40 transplanted patients are surviving from 1.5 to 59 mo, with a median follow-up of 24 mo. The actuarial survival rate for these heavily transfused patients with aplastic anemia is 72% at 2 yr. This preparative regimen is extremely effective in decreasing rejection following transplantation for severe aplastic anemia. Future efforts in this area must be aimed at the elimination of graft-versus-host disease and control of fatal infections.
对40例接受异基因骨髓移植的重型再生障碍性贫血患者采用了由全身淋巴照射和环磷酰胺组成的预处理方案。该方案成功降低了这些既往输血患者的排斥反应,因为只有1例患者排斥骨髓移植物。40例移植患者中有29例存活了1.5至59个月,中位随访时间为24个月。这些重度输血的再生障碍性贫血患者2年的实际生存率为72%。这种预处理方案在降低重型再生障碍性贫血移植后的排斥反应方面极其有效。该领域未来的工作必须致力于消除移植物抗宿主病和控制致命感染。